BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2016-01225 Ergospirometry in pediatric cardiology: analysis of current practice and standardization of procedure personal data/biological material monocentric Dr Yvan Mivelaz CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 29.09.2016
2016-01223 Vaporisateurs portables: fonctionnement, efficacité et risques de contamination par le cannabis non clinical, involving persons monocentric A PD Dr. / Christian / Giroud Centre Universitaire Romand de Médecine Légale CURML, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 06.09.2016 Study has ended
2016-01220 Effects of a Virtual Reality-based dual-task exercise on vestibular function in healthy community dwellers. A pilot study clinical trial medical devices monocentric A Dr. Jaap Swanenburg University Hospital Zurich University Hospital Zurich, Zurich
Kantonale Ethikkommission Zürich 13.03.2017 Study has ended
2016-01219 Lebensqualität und Inzidenz von Rezidivoperationen nach rekonstruktiven Eingriffen beim weiblichen Genitaldeszensus 2005 - 2015 non clinical, involving persons monocentric A Dr. med. Cornelia Betschart Department of Gynecology Department of Gynecology, University Hospital Zürich, Zürich
Kantonale Ethikkommission Zürich 09.11.2016 Study has ended
2016-01218 Title: Microvasculature and lenalidomide in Acute Myeloid Leukemia

EKBB Nr. 172/11
HOVON 103 - SAKK 30/10. A program of randomised phase II multicenter studies to assess the tolerability and effic More ...
personal data/biological material monocentric PD Dr. Michael Medinger Swiss Group for Clinical Cancer Research SAKK University Hospital, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 02.08.2016
2016-01217 Botulinum-A Toxin injection in children with neuropathic bladder dysfunction – at least 3 years after first Botox injection personal data/biological material monocentric Prof. Dr. med. Rita Gobet Kinderspital Zürich, Zurich
Kantonale Ethikkommission Zürich 14.12.2016
2016-01216 Charakterisierung des Rebound-Phänomen bei Patientinnen nach Stopp von Denosumab zur Prävention oder Therapie einer Osteoporose.
personal data/biological material monocentric PD Dr. med. Albrecht Popp Universitätspoliklinik für Osteoporose Universitätspoliklinik für Osteoporose, Inselspital, Bern
Kantonale Ethikkommission Bern 06.10.2016
2016-01215 The laser hemorrhoidoplasty procedure: a 5-year follow up measuring recurrence rate and patient satisfaction. non clinical, involving persons monocentric A Manolis Pratsinis Klinik für Allgemein-, Viszeral- und Gefässchirurgie Kantonsspital Baden, Baden
Ethikkommission Nordwest- und Zentralschweiz EKNZ 27.10.2016 Study has ended
2016-01214 The SPACER Trial – Repair of Tricuspid Valve Regurgitation using the Edwards FORMA TricuSPid TrAnsCatheter REpaiR System clinical trial medical devices monocentric C2 MD, Stephan Windecker Edwards Lifesciences LLC Inselspital, Universitatsspital Bern, Bern
Kantonale Ethikkommission Bern 08.02.2017 Study has ended
2016-01213 Retrospektive Analyse der Gerinnungsparameter (ROTEM und FXIII) bei Kindern unter ECMO Therapie
personal data/biological material monocentric Prof. Dr. Thorsten Haas Universitäts-Kinderpital Zürich Universitäts-Kinderspital Zürich, Zürich
Kantonale Ethikkommission Zürich 08.08.2016
2016-01212 Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Terguride Plus Symptomatic Therapy in Subjects With Diffuse Cutaneous Systemic Sclerosis (TERGISS More ... clinical trial drugs phase 3 monocentric C Dr. Britta Maurer medac GmbH Universitätsspital Zürich, Zürich
Kantonale Ethikkommission Zürich 17.02.2017 Study has ended
2016-01211 A Phase IIa, Single Blind, Randomized, Study to Evaluate the Safety, the Immunogenicity, and the Clinical and Biological Efficacy of IFNα-Kinoid (IFN-K) in Adult Subjects with Dermatomyositis clinical trial drugs phase 2 monocentric C Prof. Francois Spertini Neovacs SA CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 27.09.2016 Study has ended
2016-01210 Swiss Cohort of Persons with Disorders of Sex Development non clinical, involving persons multicentric A Prof. Dr. med. Christa Flück Department of Pediatric Endocrinology & Diabetology, University Children's Hospital Bern Department of Pediatric Endocrinology & Diabetology, University Children's Hospital Bern, Bern
Institute for Social and Preventive Medicine, University of Bern, Bern
Pädiatrische Endokrinologie/Diabet More ...
Kantonale Ethikkommission Bern Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche s More ... 20.02.2017 yes
2016-01209 MK8931-019 (Extension): A Parallel-Group, Double-Blind, Long Term Safety and Efficacy Trial of MK-8931 (SCH900931) in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease (Prodr More ... clinical trial drugs phase 3 monocentric C Dr. med. Anton Gietl Merck Sharp & Dohme AG Institut für Regenerative Medizin - IREM, 8952 Schlieren
Kantonale Ethikkommission Zürich 27.09.2016 Study has ended
2016-01207 USABILITY STUDIE EINES PROTOTYPS DES ROLL-WALKERS®, EINER NEUARTIGEN GEHHILFE clinical trial medical devices monocentric C Prof. Dr. Karin Niedermann Zürcher Hochschule für angewandte Wissenschaften Zürcher Hochschule für angewandte Wissenschaften, Winterthur
Kantonale Ethikkommission Zürich 10.11.2016 Study has ended
2016-01206 Treatment of 407 temporomandibular pain patients with microsystem acupuncture personal data/biological material monocentric Dr. Johannes Fleckenstein University of Bern University of Bern, Bern
Kantonale Ethikkommission Bern 26.01.2017
2016-01205 A Phase II randomized, double-blind (Part A, B and C), placebo controlled
(Part A and B only), study to assess safety, tolerability and efficacy of
MCS110 on tumor size in patients with pigmented vi More ...
clinical trial drugs phase 2 monocentric C PD Dr. A. Krieg Novartis Pharma Switzerland AG Universitätsspital beider Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 19.09.2016 yes Study has ended
2016-01204 CLCI699C2302 A Phase III, multi-center, randomized, double-blind, 48 week study with an initial 12 week placebo-controlled period to evaluate the safety and efficacy of osilodrostat in patients with C More ... clinical trial drugs phase 3 multicentric C Prof. Dr. med. Emanuel Christ Novartis Pharma Schweiz AG Insel Gruppe AG, Bern
Luzerner Kantonsspital, Luzern
Universitätsspital Zürich, Zürich
Kantonale Ethikkommission Bern Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Zürich 07.12.2016 Study has ended
2016-01203 Evaluation der notwendigen Bildqualität von DVT-Aufmahmen im Rahmen der erweiterten radiologischen Diagnostik im dentomaxillofazialen Bereich deceased persons monocentric Prof. Carlalberta Verna UZB Universitäres Zentrum für Zahnmedizin Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 14.09.2016
2016-01202 It's impossible to estimate the Need for reversal of neuromuscular Relaxation at the end of anesthesia. A retrospective analyzis of rocuronium dosing patterns personal data/biological material monocentric Prof. Dr. med. Peter Biro Univeristätsspital Zürich Universitätsspital Zürich, Zürich
Kantonale Ethikkommission Zürich 13.10.2016